• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
TIGIT signaling restores suppressor function of Th1 Tregs.TIGIT信号传导可恢复Th1调节性T细胞的抑制功能。
JCI Insight. 2019 Feb 7;4(3):e124427. doi: 10.1172/jci.insight.124427.
2
TIGIT reverses IFN-α-promoted Th1-like Tregs via in-sequence effects dependent on STAT4.TIGIT 通过依赖于 STAT4 的顺序效应逆转 IFN-α 促进的 Th1 样调节性 T 细胞。
Arthritis Res Ther. 2023 Nov 17;25(1):221. doi: 10.1186/s13075-023-03202-8.
3
AKT isoforms modulate Th1-like Treg generation and function in human autoimmune disease.AKT亚型在人类自身免疫性疾病中调节Th1样调节性T细胞的产生和功能。
EMBO Rep. 2016 Aug;17(8):1169-83. doi: 10.15252/embr.201541905. Epub 2016 Jun 16.
4
Clinical Remission of Sight-Threatening Non-Infectious Uveitis Is Characterized by an Upregulation of Peripheral T-Regulatory Cell Polarized Towards T-bet and TIGIT.威胁视力的非感染性葡萄膜炎的临床缓解表现为外周 T 调节细胞向 T-bet 和 TIGIT 极化的上调。
Front Immunol. 2018 May 3;9:907. doi: 10.3389/fimmu.2018.00907. eCollection 2018.
5
Regulatory T cells inhibit acute IFN-γ synthesis without blocking T-helper cell type 1 (Th1) differentiation via a compartmentalized requirement for IL-10.调节性 T 细胞通过对 IL-10 的分隔需求抑制急性 IFN-γ 合成,而不阻断 T 辅助细胞 1(Th1)分化。
Proc Natl Acad Sci U S A. 2011 Nov 8;108(45):18336-41. doi: 10.1073/pnas.1110566108. Epub 2011 Oct 24.
6
Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.Th17细胞在中枢神经系统炎性脱髓鞘发病机制中的作用。
J Neurol Sci. 2013 Oct 15;333(1-2):76-87. doi: 10.1016/j.jns.2013.03.002. Epub 2013 Apr 8.
7
Thymol as a reciprocal regulator of T cell differentiation: Promotion of regulatory T cells and suppression of Th1/Th17 cells.百里酚作为 T 细胞分化的反向调节剂:促进调节性 T 细胞并抑制 Th1/Th17 细胞。
Int Immunopharmacol. 2019 Feb;67:417-426. doi: 10.1016/j.intimp.2018.12.021. Epub 2018 Dec 31.
8
Myelin-reactive, TGF-β-induced regulatory T cells can be programmed to develop Th1-like effector function but remain less proinflammatory than myelin-reactive Th1 effectors and can suppress pathogenic T cell clonal expansion in vivo.髓鞘反应性、TGF-β诱导的调节性 T 细胞可被编程发展为 Th1 样效应功能,但比髓鞘反应性 Th1 效应物的炎症反应性更低,并且可以在体内抑制致病性 T 细胞克隆扩增。
J Immunol. 2010 Dec 15;185(12):7235-43. doi: 10.4049/jimmunol.1001551. Epub 2010 Nov 17.
9
Production of Proinflammatory Cytokines by Monocytes in Liver-Transplanted Recipients with De Novo Autoimmune Hepatitis Is Enhanced and Induces TH1-like Regulatory T Cells.新发自身免疫性肝炎肝移植受者单核细胞促炎细胞因子的产生增强并诱导TH1样调节性T细胞。
J Immunol. 2016 May 15;196(10):4040-51. doi: 10.4049/jimmunol.1502276. Epub 2016 Apr 18.
10
Induction of IL-10 suppressors in lung transplant patients by CD4+25+ regulatory T cells through CTLA-4 signaling.CD4+25+调节性T细胞通过CTLA-4信号通路诱导肺移植患者体内的IL-10抑制因子。
J Immunol. 2006 Oct 15;177(8):5631-8. doi: 10.4049/jimmunol.177.8.5631.

引用本文的文献

1
TIGIT in cancer: from mechanism of action to promising immunotherapeutic strategies.癌症中的TIGIT:从作用机制到有前景的免疫治疗策略
Cell Death Dis. 2025 Sep 1;16(1):664. doi: 10.1038/s41419-025-07984-4.
2
The homeostasis and heterogeneity of regulatory T cells in sepsis.脓毒症中调节性T细胞的稳态与异质性
Burns Trauma. 2025 Jul 15;13:tkaf047. doi: 10.1093/burnst/tkaf047. eCollection 2025.
3
Pharmacological and structural characterization of vibostolimab, a novel anti-TIGIT blocking antibody for cancer immunotherapy.维博妥利单抗(vibostolimab)的药理学和结构特征,一种用于癌症免疫治疗的新型抗TIGIT阻断抗体。
J Immunother Cancer. 2025 Aug 18;13(8):e008972. doi: 10.1136/jitc-2024-008972.
4
The Multifaceted Role of Regulatory T Cells in Sepsis: Mechanisms, Heterogeneity, and Pathogen-Tailored Therapies.调节性T细胞在脓毒症中的多方面作用:机制、异质性及病原体针对性疗法
Int J Mol Sci. 2025 Aug 1;26(15):7436. doi: 10.3390/ijms26157436.
5
Unraveling the complexities of diet induced obesity and glucolipid dysfunction in metabolic syndrome.解析代谢综合征中饮食诱导的肥胖和糖脂功能障碍的复杂性。
Diabetol Metab Syndr. 2025 Jul 22;17(1):292. doi: 10.1186/s13098-025-01837-y.
6
Tiragolumab and TIGIT: pioneering the next era of cancer immunotherapy.替雷利珠单抗与TIGIT:开创癌症免疫治疗的新时代。
Front Pharmacol. 2025 Jun 11;16:1568664. doi: 10.3389/fphar.2025.1568664. eCollection 2025.
7
The dual role of TIGIT in regulatory and effector T cells in chronic liver disease.TIGIT在慢性肝病调节性T细胞和效应T细胞中的双重作用。
JHEP Rep. 2025 Mar 29;7(6):101405. doi: 10.1016/j.jhepr.2025.101405. eCollection 2025 Jun.
8
Immune inhibitory receptor agonist therapeutics.免疫抑制受体激动剂疗法。
Front Immunol. 2025 Mar 26;16:1566869. doi: 10.3389/fimmu.2025.1566869. eCollection 2025.
9
Transcriptomic profiling after B cell depletion reveals central and peripheral immune cell changes in multiple sclerosis.B细胞耗竭后的转录组分析揭示了多发性硬化症中中枢和外周免疫细胞的变化。
J Clin Invest. 2025 Mar 11;135(11). doi: 10.1172/JCI182790. eCollection 2025 Jun 2.
10
Disease-modifying pharmacological treatments of type 1 diabetes: Molecular mechanisms, target checkpoints, and possible combinatorial treatments.1型糖尿病的疾病修饰性药物治疗:分子机制、靶点检查点及可能的联合治疗
Pharmacol Rev. 2025 Mar;77(2):100044. doi: 10.1016/j.pharmr.2025.100044. Epub 2025 Jan 23.

TIGIT信号传导可恢复Th1调节性T细胞的抑制功能。

TIGIT signaling restores suppressor function of Th1 Tregs.

作者信息

Lucca Liliana E, Axisa Pierre-Paul, Singer Emily R, Nolan Neal M, Dominguez-Villar Margarita, Hafler David A

机构信息

Departments of Neurology and Immunobiology, Yale School of Medicine, New Haven, Connecticut, USA.

Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.

出版信息

JCI Insight. 2019 Feb 7;4(3):e124427. doi: 10.1172/jci.insight.124427.

DOI:10.1172/jci.insight.124427
PMID:30728325
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6413794/
Abstract

Th1 Tregs are characterized by the acquisition of proinflammatory cytokine secretion and reduced suppressor activity. Th1 Tregs are found at increased frequency in autoimmune diseases, including type 1 diabetes and multiple sclerosis (MS). We have previously reported that in vitro stimulation with IL-12 recapitulates the functional and molecular features of MS-associated Th1 Tregs, revealing a central role for hyperactivation of the Akt pathway in their induction. TIGIT is a newly identified coinhibitory receptor that marks Tregs that specifically control Th1 and Th17 responses. Here, we report that signaling through TIGIT counteracts the action of IL-12 in inducing the Th1 program. Specifically, TIGIT signaling represses production of IFN-γ and T-bet expression and restores suppressor function in Tregs treated with IL-12. FoxO1 functional inhibition abolishes the protective effect of TIGIT, indicating that TIGIT signaling promotes FoxO1 nuclear localization. Consistent with this observation, signaling through TIGIT leads to a rapid suppression of Akt function and FoxO1 phosphorylation. Finally, TIGIT stimulation reduces the production of IFN-γ and corrects the suppressor defect of Tregs from patients with MS. Our results indicate an important role for TIGIT in controlling the functional stability of Tregs through repression of Akt, suggesting that the TIGIT pathway could be targeted for immunomodulatory therapies in human autoimmune disorders.

摘要

Th1调节性T细胞的特征是获得促炎细胞因子分泌能力且抑制活性降低。在包括1型糖尿病和多发性硬化症(MS)在内的自身免疫性疾病中,Th1调节性T细胞的频率增加。我们之前报道过,用白细胞介素-12进行体外刺激可重现与MS相关的Th1调节性T细胞的功能和分子特征,揭示了Akt途径的过度激活在其诱导过程中的核心作用。TIGIT是一种新发现的共抑制受体,可标记特异性控制Th1和Th17反应的调节性T细胞。在此,我们报道通过TIGIT发出的信号可抵消白细胞介素-12在诱导Th1程序中的作用。具体而言,TIGIT信号传导可抑制干扰素-γ的产生和T-bet表达,并恢复用白细胞介素-12处理的调节性T细胞的抑制功能。FoxO1功能抑制可消除TIGIT的保护作用,表明TIGIT信号传导促进FoxO1核定位。与这一观察结果一致,通过TIGIT发出的信号会导致Akt功能和FoxO1磷酸化迅速受到抑制。最后,TIGIT刺激可减少干扰素-γ的产生,并纠正MS患者调节性T细胞的抑制缺陷。我们的结果表明,TIGIT在通过抑制Akt来控制调节性T细胞的功能稳定性方面具有重要作用,这表明TIGIT途径可作为人类自身免疫性疾病免疫调节治疗的靶点。